ADMA Biologics IncADMA Biologics IncADMA Biologics Inc

ADMA Biologics Inc

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.13 B‬USD
‪−28.24 M‬USD
‪258.21 M‬USD
‪223.07 M‬
Beta (1Y)

About ADMA Biologics Inc

Adam S. Grossman
Employees (FY)
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ADMA is 9.45 USD — it has increased by 0.43% in the past 24 hours. Watch ADMA Biologics Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ADMA Biologics Inc stocks are traded under the ticker ADMA.
ADMA stock has risen by 8.00% compared to the previous week, the month change is a 52.42% rise, over the last year ADMA Biologics Inc has showed a 129.37% increase.
We've gathered analysts' opinions on ADMA Biologics Inc future price: according to them, ADMA price has a max estimate of 12.00 USD and a min estimate of 10.00 USD. Watch ADMA chart and read a more detailed ADMA Biologics Inc stock forecast: see what analysts think of ADMA Biologics Inc and suggest that you do with its stocks.
ADMA reached its all-time high on Dec 3, 2014 with the price of 14.00 USD, and its all-time low was 1.01 USD and was reached on Oct 21, 2021. View more price dynamics on ADMA chart.
See other stocks reaching their highest and lowest prices.
ADMA stock is 3.22% volatile and has beta coefficient of 1.31. Track ADMA Biologics Inc stock price on the chart and check out the list of the most volatile stocks — is ADMA Biologics Inc there?
Today ADMA Biologics Inc has the market capitalization of ‪2.18 B‬, it has increased by 3.50% over the last week.
Yes, you can track ADMA Biologics Inc financials in yearly and quarterly reports right on TradingView.
ADMA Biologics Inc is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ADMA earnings for the last quarter are 0.09 USD per share, whereas the estimation was 0.06 USD resulting in a 61.92% surprise. The estimated earnings for the next quarter are 0.08 USD per share. See more details about ADMA Biologics Inc earnings.
ADMA Biologics Inc revenue for the last quarter amounts to ‪81.88 M‬ USD despite the estimated figure of ‪77.28 M‬ USD. In the next quarter revenue is expected to reach ‪86.44 M‬ USD.
ADMA net income for the last quarter is ‪17.81 M‬ USD, while the quarter before that showed ‪−17.64 M‬ USD of net income which accounts for 200.92% change. Track more ADMA Biologics Inc financial stats to get the full picture.
No, ADMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 21, 2024, the company has 624.00 employees. See our rating of the largest employees — is ADMA Biologics Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADMA Biologics Inc EBITDA is ‪52.68 M‬ USD, and current EBITDA margin is 11.60%. See more stats in ADMA Biologics Inc financial statements.
Like other stocks, ADMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADMA Biologics Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADMA Biologics Inc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADMA Biologics Inc stock shows the strong buy signal. See more of ADMA Biologics Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.